JG

Active Director Director DIN 08235195
DIN 08235195 First appointment Sep 2018 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Sep 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About July Gray

Data last updated:

July Gray is a Director at Adosis Pharmaceutical Private Limited (since 2021) and Director at Vetkem Pharma Private Limited (since 2018). The companies operate in Pharma and Food And Beverages.

DIN 08235195
Primary Designation Director
Industry Pharma
First Appointment 21 Sep 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Nov 20212021Active
Vetkem Pharma Private Limited U24304HP2018PTC007170
Director21 Sep 20182018Active

Board colleagues of July Gray

Directorship timeline

Open interactive timeline →
Adosis Pharmaceutical Private Limited
Vetkem Pharma Private Limited
Premium access

Shareholding and investment profile for July Gray

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about July Gray

July Gray currently holds 2 directorships: Adosis Pharmaceutical Private Limited (Director, since 29 Nov 2021); Vetkem Pharma Private Limited (Director, since 21 Sep 2018).

July Gray was first appointed on 21 Sep 2018 as Director at Vetkem Pharma Private Limited. The most recent appointment on record is 29 Nov 2021 at Adosis Pharmaceutical Private Limited.

The current boards of July Gray's companies include Prabhash Kumar (Adosis Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available